8-KFiled Mar 26, 8:00 PM ET
ADMA Biologics Issues Press Release Under Regulation FD
$ADMA · ADMA BIOLOGICS, INC.Research Summary
AI-generated summary of this SEC filing
ADMA Biologics Issues Press Release Under Regulation FD
What Happened
- On March 27, 2026, ADMA Biologics, Inc. (ADMA) filed a Form 8-K reporting a Regulation FD disclosure: the company issued a press release that is furnished as Exhibit 99.1 and incorporated by reference in the filing.
Key Details
- Filing date: March 27, 2026 (Form 8-K, Item 7.01).
- Disclosure type: Regulation FD press release furnished as Exhibit 99.1.
- The filing also includes an interactive XBRL cover page (Exhibit 104).
Why It Matters
- This 8-K notifies investors that ADMA publicly released information via a press release on March 27, 2026. Investors should read the attached Exhibit 99.1 press release to see the specific news or updates the company disclosed.